Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes

Dyslipidemia associated with triglyceride-rich lipoproteins (TRLs) represents an important residual risk factor for cardiovascular and chronic kidney disease in patients with type 1 diabetes (T1D). Levels of growth hormone (GH) are elevated in T1D, which aggravates both hyperglycemia and dyslipidemi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Proc Natl Acad Sci U S A
Egile Nagusiak: Romero, Maritza J., Lucas, Rudolf, Dou, Huijuan, Sridhar, Supriya, Czikora, Istvan, Mosieri, Eby M., Rick, Ferenc G., Block, Norman L., Sridhar, Subbaramiah, Fulton, David, Weintraub, Neal L., Bagi, Zsolt, Schally, Andrew V.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: National Academy of Sciences 2016
Gaiak:
Biological Sciences
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4763773/
https://ncbi.nlm.nih.gov/pubmed/26831066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1525520113
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak